You are here: Home » PTI Stories » National » News
Business Standard

Zydus Cadila announces phase III trials of Desidustat

Press Trust of India  |  New Delhi 

Drug firm Wednesday announced phase III clinical trials of Desidustat, an targeted at treating in non-dependent patients.

"This phase III study will be a multicenter (50-60 sites), randomised, active-controlled clinical trial to evaluate the efficacy and safety of versus Darbepoetin for the treatment of anaemia in patients with (CKD) who are not on dialysis," the company said in a regulatory filing.

said this innovation has the potential to bring about a paradigm shift in the management of CKD patients with

Earlier, had met its primary endpoints in the phase II clinical study of non-dependent patients suffering from

The phase I trials were earlier completed in Australia, the company said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, April 17 2019. 11:15 IST